logo
Sign in

AMGN Stock Price, Chart, Stats & News

186.05B
Market cap
23.97x
Current P/E
15.17x
Forward P/E
2.84%
Dividend yield

AMGN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
70.49%
Operating margin
27.99%
Pretax margin
24.41%
Net margin
20.97%
Effective tax rate
14.09%
ROA
8.51%
ROE
96.65%
D/E
6.31x
Interest coverage ratio
3.72x

AMGN valuation

P/E
23.97x
P/S
5.11x
P/B
21.71x
P/CF
18.88x
P/FCF
23.21x
P/OCF
18.88x
PEG
2.44x
EV multiple
7.63x

About

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products.

Similar securities

Based on sector and market capitalization

Report issue